Pineridge Advisors LLC Invests $35,000 in Teleflex Incorporated (NYSE:TFX)

Pineridge Advisors LLC bought a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm bought 141 shares of the medical technology company’s stock, valued at approximately $35,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Covestor Ltd grew its position in shares of Teleflex by 305.6% during the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after purchasing an additional 110 shares in the last quarter. Lindbrook Capital LLC grew its holdings in Teleflex by 75.3% during the 4th quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock valued at $34,000 after buying an additional 58 shares in the last quarter. Massmutual Trust Co. FSB ADV increased its stake in Teleflex by 418.5% in the 4th quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock worth $35,000 after acquiring an additional 113 shares during the last quarter. Janiczek Wealth Management LLC raised its holdings in shares of Teleflex by 227.1% during the 4th quarter. Janiczek Wealth Management LLC now owns 157 shares of the medical technology company’s stock worth $39,000 after acquiring an additional 109 shares in the last quarter. Finally, Cary Street Partners Investment Advisory LLC boosted its position in shares of Teleflex by 1,333.3% during the 3rd quarter. Cary Street Partners Investment Advisory LLC now owns 215 shares of the medical technology company’s stock valued at $42,000 after acquiring an additional 200 shares during the last quarter. 95.62% of the stock is currently owned by institutional investors.

Teleflex Trading Down 0.5 %

TFX stock traded down $1.01 during trading on Friday, hitting $208.29. The company had a trading volume of 193,248 shares, compared to its average volume of 551,435. The firm has a market capitalization of $9.81 billion, a P/E ratio of 33.43, a PEG ratio of 2.02 and a beta of 1.16. The company has a quick ratio of 1.41, a current ratio of 2.51 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 52-week low of $177.63 and a 52-week high of $262.97. The company has a 50 day simple moving average of $209.89 and a 200-day simple moving average of $227.94.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share for the quarter, beating the consensus estimate of $3.07 by $0.14. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The firm had revenue of $737.80 million during the quarter, compared to the consensus estimate of $726.85 million. During the same quarter in the previous year, the firm posted $3.09 earnings per share. The company’s revenue was up 3.8% on a year-over-year basis. As a group, research analysts forecast that Teleflex Incorporated will post 13.75 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, June 14th. Stockholders of record on Wednesday, May 15th were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date was Tuesday, May 14th. Teleflex’s payout ratio is 21.83%.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on TFX shares. JMP Securities reaffirmed a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a research note on Friday, February 23rd. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. StockNews.com lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial decreased their price target on Teleflex from $240.00 to $219.00 and set a “hold” rating on the stock in a report on Friday, May 3rd. Finally, Royal Bank of Canada cut their price objective on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex has an average rating of “Moderate Buy” and a consensus price target of $257.29.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.